HIV-associated anaerobes ferment TB risk

Area of Science:

• Microbiology
• Infectious Diseases
• Immunology

Background:

• Tuberculosis (TB) remains a significant global health challenge, particularly for individuals with Human Immunodeficiency Virus (HIV).
• Antiretroviral therapy (ART) has improved outcomes for HIV-infected individuals but does not eliminate all opportunistic infections.
• The gut microbiome's role in modulating immune responses and susceptibility to infections is an emerging area of research.

Purpose of the Study:

• To investigate the association between short-chain fatty acids (SCFAs), microbial metabolites, and the risk of developing TB.
• To explore potential mechanisms linking gut dysbiosis to increased TB incidence in HIV-infected individuals on ART.

Main Methods:

• Analysis of SCFA levels in study participants.
• Correlation of SCFA concentrations with TB incidence.
• Assessment of host immune markers in relation to SCFA profiles.

Main Results:

• Elevated levels of specific SCFAs were significantly associated with an increased risk of TB.
• Certain SCFA profiles correlated with altered immune cell populations and function.
• The findings suggest a direct link between SCFA production and TB susceptibility.

Conclusions:

• Gut-derived SCFAs may play a crucial role in increasing TB risk among HIV-positive individuals on ART.
• Targeting the gut microbiome or SCFA production could represent a novel therapeutic strategy to prevent TB in this population.
• Further research is warranted to elucidate the precise mechanisms involved.